Paul Tebbey

Paul Tebbey currently serves as the Chief Operating Officer at Direct Biologics, a position held since October 2023. As a Board Member at Radyus Research since 2020, Paul has significant experience in leadership roles across the biopharmaceutical industry. Previous roles include Chief Operating Officer at Elusys Therapeutics and Senior Vice-President of Product Development & Portfolio Strategy at NightHawk Biosciences. Paul's expertise in medical affairs is highlighted by a tenure as Vice President at both Fresenius Kabi USA and AbbVie, where noteworthy contributions were made in oncology and biosimilars. Earlier career milestones include positions at Baxter International, Kolabri Consulting, Genactis, and Johnson & Johnson, focusing on global marketing, product development, and strategic marketing for biotherapeutics. Paul holds an MBA in Marketing from the Rochester Institute of Technology and a Ph.D. in Microbiology & Immunology from East Carolina University, alongside a B.Sc. in Applied Biologic Sciences from the University of the West of England.